• Rapid Dose Therapeutics expanded its distribution and sales collaboration with Bodhi Health for CurcuWIN QuickStrip curcumin across Canada.
• Rapid Dose manufactures the oral thin-film product; Bodhi Health acts as Canadian distributor and North American supplier of the finished product.
• Partners cited more than 300,000 units sold to date, positioning the rollout to capture rising retailer and practitioner demand.
• Agreement makes the CurcuWIN formulation available exclusively via Rapid Dose in an oral thin-film format.
• Bodhi Health plans to use CHFA NOW Toronto on Sept. 25-27, 2026 to pursue additional Canadian and North American distribution opportunities.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rapid Dose Therapeutics Corp. published the original content used to generate this news brief via pressetext (Ref. ID: 202607290444PRESSTXTEUPR__DE3410FEDB0FACDC48DE5E8A8322FDC96) on July 29, 2026, and is solely responsible for the information contained therein.